Image 1
Potassium Citrate Tablet, Extended Release
Product Images NDC 0591-2682
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Potassium Citrate (NDC 0591-2682). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image 2
This is a description of prescription medication, Potassium Citrate, in extended-release tablets form. The tablets are round-shaped, uncoated, and yellowish with speckles. It comes in a bottle containing 100 tablets, and each tablet is debossed with "AG7" on one side and plain on the other. Dosages can be found on the package insert. It should be stored between 20°C and 25°C in a tight container, away from children. The medication is manufactured by Watson Pharma Private Ltd in India and packaged by Teva Pharmaceuticals in Parsippany, NJ. The provided information is valid until August 2022.*
Image 3
This is a description of a medication - Potassium Citrate Extended-Release Tablets, USP with NDC 0591-2729-01 manufactured by Teva. Each tablet contains 10 meq of the medicine and is debossed with AS4 on one side and plain on the other side. The tablets are tan to yellowish, speckled, uncoated, and modified capsule shaped. The package insert contains full prescribing information. The medication needs to be stored at 20°C to 25°C, and it should be kept in a tight container. It is recommended to keep the medication away from the reach of children. There is also information about the manufacturer and serialization coding area.*
Image 4
This is a description for a medication with the NDC code 0591-2742-01. The medication is called Potassium Citrate and comes in extended-release tablets form with each tablet containing 15 mEq. It is available in a 100 tablet package with prescription only. The tablet is oval shaped, speckled, uncoated, and modified, and is either tan or yellowish in color. The tablets should be stored in a tight container and kept at a temperature of 20°C to 25°C. The unit of use package should be dispensed without repackaging, and the package insert should be given together with the bottle. The medication is manufactured by Watson Pharma Private Ltd in India and distributed by Teva Pharmaceuticals in Parsippany, NJ. Additional information, including the dosage, should be accessed through the package insert. The description includes a warning to keep the medication out of the reach of children. The text also includes lot/exp numbers and an area for coding information for customization.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
